Week 4 Content Flashcards
Assessment of High-Risk Pregnancy
What is high-risk?
⚬ A pregnancy in which the life or health of the mother or fetus is jeopardized by a disorder coincidental with or unique to __________.
■ Extends through peurperium (____ weeks after birth)
⚬ Early and regular prenatal care allows for identification of risk, mortality rates decrease and outcomes improve
⚬ A pregnancy in which the life or health of the mother or fetus is jeopardized by a disorder coincidental with or unique to pregnancy.
■ Extends through peurperium (4-6 weeks after birth)
⚬ Early and regular prenatal care allows for identification of risk, mortality rates decrease and outcomes improve
Assessment of High-Risk Pregnancy
* Categories of risk:
⚬ ____________
■ Genetic, nutritional and health (medical & obstetric)
⚬ ____________
■ Smoking, caffeine, alcohol, drugs, psychologic
⚬ ____________
■ Low income, lack of prenatal care, age, parity, marital status, social determinants of health, ethnicity
⚬ ____________
■ Workplace hazards, chemicals, anesthetic gases, radiation
⚬ Biophysical
■ Genetic, nutritional and health (medical & obstetric)
⚬ Psychosocial
■ Smoking, caffeine, alcohol, drugs, psychologic
⚬ Sociodemographic
■ Low income, lack of prenatal care, age, parity, marital status, social determinants of health, ethnicity
⚬ Environmental
■ Workplace hazards, chemicals, anesthetic gases, radiation
Danger Signs During Pregnancy
- Vaginal _________ with or without discomfort
- _________ of membranes
- _________ of fingers, puffiness of face or around eyes
- Continuous, pounding _________
- _________ distubrances (blurred vision, dimness, spots)
- Persistent or severe _________ pain
- Chills or fever
- Painful urination
- Persistent vomiting
- _________ in frequency or strength of fetal movements
- Signs of preterm labor: uterine contractions, cramps, constant or irregular low backache, pelvic pressure
- Vaginal bleeding with or without discomfort
- Rupture of membranes
- Swelling of fingers, puffiness of face or around eyes
- Continuous, pounding headache
- Visual distubrances (blurred vision, dimness, spots)
- Persistent or severe abdominal pain
- Chills or fever
- Painful urination
- Persistent vomiting
- Changes in frequency or strength of fetal movements
- Signs of preterm labor: uterine contractions, cramps, constant or irregular low backache, pelvic pressure
Assessment of High-Risk Pregnancy
* Antepartum Testing: ⚬ Two major goals
■ Identify fetuses at risk for injury due to interrupted __________ so that permanent
injury or death may be prevented
■ Identity appropriately __________ fetuses so that unnecessary intervention can be avoided.
■ Identify fetuses at risk for injury due to interrupted oxygenation so that permanent
injury or death may be prevented
■ Identity appropriately oxygenated fetuses so that unnecessary intervention can be avoided.
Biophysical Assessment
- Daily Fetal __________ Count (DFMC)
⚬ Kick counts (2 types) - non-invasive
■ Count all movements in 12-hour period until fetus has moved 10 times
■ Count movement 2 or 3 times daily until 10 movements counted
⚬ If movement decreased from prior day or unable to count 10 movements, call provider
⚬ Warning sign:
■ No fetal movement for _________ is fetal alarm signal…Call provider immediately!
- Daily Fetal Movement Count (DFMC)
⚬ Kick counts (2 types) - non-invasive
■ Count all movements in 12-hour period until fetus has moved 10 times
■ Count movement 2 or 3 times daily until 10 movements counted
⚬ If movement decreased from prior day or unable to count 10 movements, call provider
⚬ Warning sign:
■ No fetal movement for 12 hours is fetal alarm signal…Call provider immediately!
Biophysical Assessment cont’d
____________ - Fetal well-being
⚬ Indications for use
■ Fetal heart rate activity – (as of 6 wks)
■ Gestational age
■ Fetal growth – (IUGR)
■ Fetal anatomy
■ Fetal genetic disorders –nuchal translucency (NT)
■ Placental position and function – (migration up from early pregnancy)
■ Adjunct to other invasive tests – amniocentesis, version, others
⚬ Amniotic Fluid Volume
■ Oligohydramnios - decreased fluid
■ Polyhydramnios - increased fluid
Ultrasonography - Fetal well-being
⚬ Indications for use
■ Fetal heart rate activity – (as of 6 wks)
■ Gestational age
■ Fetal growth – (IUGR)
■ Fetal anatomy
■ Fetal genetic disorders –nuchal translucency (NT)
■ Placental position and function – (migration up from early pregnancy)
■ Adjunct to other invasive tests – amniocentesis, version, others
⚬ Amniotic Fluid Volume
■ Oligohydramnios - decreased fluid
■ Polyhydramnios - increased fluid
- Ultrasonography cont’d
⚬ Biophysical Profile (BPP)
■ Real-time detailed assessment of physical and ________ characteristics
■ Noninvasive dynamic assessment based on acute/chronic markers
⚬ Modified Biophysical Profile
■ Combines nonstress test, which assesses the current fetal condition, with measurement of the quantity of amniotic fluid, an indicator of placental function over a longer period of time
■ ___________ volume determined by measuring a single deepest pocket of fluid instead of using the AFI (amniotic fluid index).
■ Desired test results are a reactive nonstress test and a single deepest vertical pocket of amniotic fluid that is more than 2 cm (Wilson 233)
⚬ Nursing role
■ Counseling and education regarding the procedure
⚬ Biophysical Profile (BPP)
■ Real-time detailed assessment of physical and physiologic characteristics
■ Noninvasive dynamic assessment based on acute/chronic markers
⚬ Modified Biophysical Profile
■ Combines nonstress test, which assesses the current fetal condition, with measurement of the quantity of amniotic fluid, an indicator of placental function over a longer period of time
■ Amniotic fluid volume determined by measuring a single deepest pocket of fluid instead of using the AFI (amniotic fluid index).
■ Desired test results are a reactive nonstress test and a single deepest vertical pocket of amniotic fluid that is more than 2 cm (Wilson 233)
⚬ Nursing role
■ Counseling and education regarding the procedure
Biochemical Assessment
Chorionic villus sampling (CVS)
⚬ Earlier diagnosis and rapid results
⚬ Performed between 10 and 13 weeks of gestation
⚬ Removal of small ______ specimen from fetal portion of placenta (chorionic villi)
■ Can detect __________ defections but not the severity
■ Does not detect neural tube defects
■ Higher incidence of miscarriage and pain
Chorionic villus sampling (CVS)
⚬ Earlier diagnosis and rapid results
⚬ Performed between 10 and 13 weeks of gestation
⚬ Removal of small tissue specimen from fetal portion of placenta (chorionic villi)
■ Can detect chromosomal defections but not the severity
■ Does not detect neural tube defects
■ Higher incidence of miscarriage and pain
Biochemical Assessment
Amniocentesis
⚬ 14-20 weeks
⚬ Indication for use
■ ________ concerns - Women over 35 years old, family history of ___________ abnormalities
■ Can detect chromosomal issues and neural tube defects
■ Pulmonary maturity
* L/S lecithin–sphingomyelin ratio
* and S/A** ratios
■ Risk of miscarriage, infection, Rh isoimmunization, rupture of membranes, labor
Amniocentesis
⚬ 14-20 weeks
⚬ Indication for use
■ Genetic concerns - Women over 35 years old, family history of chromosomal abnormalities
■ Can detect chromosomal issues and neural tube defects
■ Pulmonary maturity
* L/S lecithin–sphingomyelin ratio
* and S/A** ratios
■ Risk of miscarriage, infection, Rh isoimmunization, rupture of membranes, labor
Biochemical Assessment cont’d
- Percutaneous _______ blood sampling (PUBS)
⚬ _____ocentesis - direct access to fetal circulation during 2nd/3rd trimester
⚬ For fetal blood sampling and transfusion
- Percutaneous umbilical blood sampling (PUBS)
⚬ Cordocentesis - direct access to fetal circulation during 2nd/3rd trimester
⚬ For fetal blood sampling and transfusion
Antepartum Assessment Using Electronic Fetal Monitoring
- Goal ⚬ Determine if the intrauterine environment is supportive to the fetus
■ ______ trimester - Indications
⚬ Diabetes, hypertension, intrauterine growth restriction, multiple gestation, oligohydramnios, decreased fetal movement, postterm pregnancy….
- Goal ⚬ Determine if the intrauterine environment is supportive to the fetus
■ Third trimester - Indications
⚬ Diabetes, hypertension, intrauterine growth restriction, multiple gestation, oligohydramnios, decreased fetal movement, postterm pregnancy….
Antepartum Assessment Using Electronic Fetal Monitoring cont’d
- Nonstress Test (NST)
⚬ FHR response to fetal activity
⚬ Procedure – external monitor
⚬ Interpretation
■ Reactive test: ____ accelerations in a ____-minute period, each lasting at least 15 seconds and peaking at least ___ beats/min above the baseline. (Before 32 weeks of gestation, an acceleration is defined as a rise of at least 10 beats/min lasting at least 10 seconds from onset to offset)
■ Nonreactive test: A test that does not demonstrate at least ____ qualifying accelerations within a ___ -minute window
- Nonstress Test (NST)
⚬ FHR response to fetal activity
⚬ Procedure – external monitor
⚬ Interpretation
■ Reactive test: Two accelerations in a 20-minute period, each lasting at least 15 seconds and peaking at least 15 beats/min above the baseline. (Before 32 weeks of gestation, an acceleration is defined as a rise of at least 10 beats/min lasting at least 10 seconds from onset to offset)
■ Nonreactive test: A test that does not demonstrate at least two qualifying accelerations within a 20-minute window
Antepartum Assessment Using Electronic Fetal Monitoring cont’d
- ___________ Stimulation (VAS)
⚬ Fetal acoustic stimulation test (FAST)
⚬ Performed in conjunction with NST
⚬ Procedure - uses sound and vibration to stimulate fetus
- Vibroacoustic Stimulation (VAS)
⚬ Fetal acoustic stimulation test (FAST)
⚬ Performed in conjunction with NST
⚬ Procedure - uses sound and vibration to stimulate fetus
Antepartum Assessment Using Electronic Fetal Monitoring cont’d
- Contraction Stress Test (CST) - rarely done now
⚬ Oxytocin Challenge Test (OCT)
⚬ Procedure
■ Nipple-stimulated contraction test
■ Oxytocin-stimulated contraction test
■ Achieve __ or more contractions in a 10 minute window
■ Provides a warning of fetal compromise earlier than NST
⚬ Interpretation - ACOG
■ Negative - no late or significant variable decelerations
■ Positive - late decelerations following > 50% of contractions
■ Equivocal
* Suspicious - intermittent late decelerations or significant variable decelerations
* Hyperstimulatory - decelerations in presence of UCs > q 2 minutes or >90 seconds
■ Unsatisfactory - < 3 UCs in 10 minutes or tracing not interpretable
- Contraction Stress Test (CST) - rarely done now
⚬ Oxytocin Challenge Test (OCT)
⚬ Procedure
■ Nipple-stimulated contraction test
■ Oxytocin-stimulated contraction test
■ Achieve 3 or more contractions in a 10 minute window
■ Provides a warning of fetal compromise earlier than NST
⚬ Interpretation - ACOG
■ Negative - no late or significant variable decelerations
■ Positive - late decelerations following > 50% of contractions
■ Equivocal
* Suspicious - intermittent late decelerations or significant variable decelerations
* Hyperstimulatory - decelerations in presence of UCs > q 2 minutes or >90 seconds
■ Unsatisfactory - < 3 UCs in 10 minutes or tracing not interpretable
Metabolic Disorders
- Diabetes mellitus
⚬ Most common __________ disorder associated with pregnancy
⚬ Pregnancy complicated by diabetes considered ________
⚬ Can be successfully managed with a multidisciplinary approach
⚬ Key to an optimal outcome is strict maternal ________ control
- Diabetes mellitus
⚬ Most common endocrine disorder associated with pregnancy
⚬ Pregnancy complicated by diabetes considered high risk
⚬ Can be successfully managed with a multidisciplinary approach
⚬ Key to an optimal outcome is strict maternal glucose control
⚬ Classification of diabetes
■ Type 1 - absolute insulin ___________
■ Type 2 - insulin ___________
■ Gestational diabetes mellitus (GDM) is any degree of glucose intolerance with onset or recognition during pregnancy, but typically diagnosed after ___ weeks gestation
■ Type 1 - absolute insulin deficiency
■ Type 2 - insulin resistance
■ Gestational diabetes mellitus (GDM) is any degree of glucose intolerance with onset or recognition during pregnancy, but typically diagnosed after 20 weeks gestation
Diabetes
⚬ Pathogenesis
■ Group of metabolic diseases characterized by ____________ resulting from defects in _________ secretion, _________ action or both
⚬ Pathogenesis
■ Group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action or both
Metabolic Disorders cont’d * Glucose Metabolism in Pregnancy
⚬ Normal pregnancy – progressive insulin resistance
⚬ Weeks 1- 8
■ ______ increase in resistance R/T human chorionic gonadotropin (HCG) and progesterone
⚬ Weeks 9 – 15
■ Estrogen and progesterone increase as placenta established
⚬ Stimulates hyperplasia of pancreas islet cells -> ______ insulin production and tissue sensitivity to insulin
⚬ Weeks 16 – 25
■ ______ in insulin blocking hormones as placenta grows
* Insures adequate transport of glucose to fetus (Human chorionic somatotropin,
human placental lactogen, prolactin)
■ By 24 weeks pancreas needs to secrete twice the pre-pregnancy insulin to maintain
normal blood glucose level
⚬ Weeks 1- 8
■ Slight increase in resistance R/T human chorionic gonadotropin (HCG) and progesterone
⚬ Weeks 9 – 15
■ Estrogen and progesterone increase as placenta established
⚬ Stimulates hyperplasia of pancreas islet cells -> increased insulin production and tissue sensitivity to insulin
⚬ Weeks 16 – 25
■ Increase in insulin blocking hormones as placenta grows
* Insures adequate transport of glucose to fetus (Human chorionic somatotropin,
human placental lactogen, prolactin)
■ By 24 weeks pancreas needs to secrete twice the pre-pregnancy insulin to maintain
normal blood glucose level
Metabolic Disorders cont’d - Glucose Metabolism in Pregnancy cont’d
⚬ Week 26 – 35
■ Endogenous insulin requirement _________
⚬ Week 36 +
■ Requirement levels off
⚬ Diabetes during pregnancy
■ Unable to double or triple their insulin secretion -> can’t overcome insulin blocking effects of placental hormones -> ___________ blood glucose levels
⚬ Week 26 – 35
■ Endogenous insulin requirement triples
⚬ Week 36 +
■ Requirement levels off
⚬ Diabetes during pregnancy
■ Unable to double or triple their insulin secretion -> can’t overcome insulin blocking effects of placental hormones -> elevated blood glucose levels
Metabolic Disorders cont’d
- Pregestational diabetes mellitus (Type 1 or 2)
⚬ Preconception counseling-
⚬ Key goal is to get blood glucose levels under control ________ and in early pregnancy.
⚬ Congenital defects related to diabetes is more likely in _____ pregnancy.
⚬ May need adjustment on medication. Most pregnant women requiring medication will need to be on _________
⚬ Preconception counseling-
⚬ Key goal is to get blood glucose levels under control before and in early pregnancy.
⚬ Congenital defects related to diabetes is more likely in early pregnancy.
⚬ May need adjustment on medication. Most pregnant women requiring medication will need to be on insulin
Metabolic Disorders cont’d
⚬ Maternal risks and complications
■ Macrosomia
■ Hydramnios/Polyhydramnios
■ Ketoacidosis
■ Hyperglycemia
■ Hypoglycemia
⚬ Fetal and neonatal risks
■ Sudden and unexplained stillbirth
■ Congenital malformations
■ Respiratory distress
■ Hypo/hyperglycemia
■ SGA/IUGR
■ LGA/Macrosomia
⚬ Maternal risks and complications
■ Macrosomia
■ Hydramnios/Polyhydramnios
■ Ketoacidosis
■ Hyperglycemia
■ Hypoglycemia
⚬ Fetal and neonatal risks
■ Sudden and unexplained stillbirth
■ Congenital malformations
■ Respiratory distress
■ Hypo/hyperglycemia
■ SGA/IUGR
■ LGA/Macrosomia
- Gestational diabetes mellitus (GDM)
⚬ Diagnosed during __________ of pregnancy
⚬ Maternal-fetal risks
⚬ Screening for gestational diabetes mellitus
■ One and two step screening
⚬ Diagnosed during 2nd half of pregnancy
⚬ Maternal-fetal risks
⚬ Screening for gestational diabetes mellitus
■ One and two step screening
Metabolic Disorders cont’d - * DM care management
⚬ Antepartum evaluation
■ Interview
■ Physical examination
■ Laboratory tests
- Baseline renal function
⚬ ____ urine collection - total protein excretion and creatinine clearance - UA and culture
- Thyroid
- Glycosylated hemoglobin A1C
■ Patient needs much more frequent monitoring
⚬ Antepartum evaluation
■ Interview
■ Physical examination
■ Laboratory tests
- Baseline renal function
⚬ 24-hr urine collection - total protein excretion and creatinine clearance - UA and culture
- Thyroid
- Glycosylated hemoglobin A1C
■ Patient needs much more frequent monitoring
Metabolic Disorders cont’d * DM care management cont’d
⚬ Antepartum care
■ Diet
■ __________ - 30-60 min daily
■ Insulin therapy
■ Monitoring blood glucose levels
* ___ times/day
* Continuous glucose monitoring (GCM)
■ Urine testing
■ Complications requiring hospitalization
■ Fetal surveillance
* NST weekly or biweekly starting 28 or 32 weeks gestation
■ Determination of birth date and mode of birth, often delivered before 39 weeks
⚬ Antepartum care
■ Diet
■ Exercise - 30-60 min daily
■ Insulin therapy
■ Monitoring blood glucose levels
* 4-8 times/day
* Continuous glucose monitoring (GCM)
■ Urine testing
■ Complications requiring hospitalization
■ Fetal surveillance
* NST weekly or biweekly starting 28 or 32 weeks gestation
■ Determination of birth date and mode of birth, often delivered before 39 weeks
Patient teaching table
Diabetes- mother nutrition
Metabolic Disorders* DM care management cont’d
⚬ Intrapartum care
■ Monitor patient closely
* Prevent _______, _________, _________
■ Complications
■ May require a _________birth
⚬ Postpartum care
■ Insulin requirements _________ substantially
■ Encourage breastfeeding
⚬ Intrapartum care
■ Monitor patient closely
* Prevent dehydration, hypoglycemia, hyperglycemia
■ Complications
■ May require a cesarean birth
⚬ Postpartum care
■ Insulin requirements decrease substantially
■ Encourage breastfeeding
Metabolic Disorders cont’d ⚬ GDM Care management
■ Antepartum care
* Immediate counseling and education
⚬ Diet and exercise
⚬ Monitoring blood glucose levels
⚬ Insulin therapy
⚬ Fetal surveillance
■ Intrapartum and postpartum care
* Reclassify 6 weeks PP
⚬ 2 hour (75 g) OGTT - if normal, repeat in 1 year
* About ___ will have recurrent GDM in subsequent pregnancies
■ Antepartum care
* Immediate counseling and education
⚬ Diet and exercise
⚬ Monitoring blood glucose levels
⚬ Insulin therapy
⚬ Fetal surveillance
■ Intrapartum and postpartum care
* Reclassify 6 weeks PP
⚬ 2 hour (75 g) OGTT - if normal, repeat in 1 year
* About 1/3 will have recurrent GDM in subsequent pregnancies
Hypertension in Pregnancy
- Significance and incidence
⚬ Most ________ medical complication of pregnancy
■ Preeclampsia - complicates _____% of all pregnancies
⚬ Major cause of maternal and perinatal morbidity and mortality
■ Reported maternal death from preeclampsia/eclampsia is 1.8 per 100,000
■ Large disparity between race
* _____________ women experience the most severe complications and have higher mortality rates
- Significance and incidence
⚬ Most common medical complication of pregnancy
■ Preeclampsia - complicates 4.5% to 11% of all pregnancies
⚬ Major cause of maternal and perinatal morbidity and mortality
■ Reported maternal death from preeclampsia/eclampsia is 1.8 per 100,000
■ Large disparity between race
* African-American women experience the most severe complications and have higher mortality rates
Hypertension in Pregnancy cont’d
Hypertension: Systolic > ___ or Diastolic > ___
* 2 occasions at least 4-6 hours apart OR
* Severe range blood pressure of Systolic >160 or Diastolic >110
- Classifications
⚬ Chronic hypertension
■ Hypertension present before pregnancy, diagnosed before ____ weeks gestations, or persists after 12 weeks PP
⚬ Gestational hypertension
■ Onset of hypertension without proteinuria after __ weeks of gestation
Hypertension: Systolic >140 or Diastolic >90
* 2 occasions at least 4-6 hours apart OR
* Severe range blood pressure of Systolic >160 or Diastolic >110
- Classifications
⚬ Chronic hypertension
■ Hypertension present before pregnancy, diagnosed before 20 weeks gestations, or persists after 12 weeks PP
⚬ Gestational hypertension
■ Onset of hypertension without proteinuria after 20 weeks of gestation
Hypertension in Pregnancy cont’d
⚬ Chronic hypertension
■ Increased incidence of:
* _______ placentae
* Superimposed preeclampsia
* Increased perinatal ________
■ PP complications:
* __________ edema
* Renal failure
* Heart failure
* Encephalopathy
* Stroke
⚬ Chronic hypertension
■ Increased incidence of:
* Abruptio placentae
* Superimposed preeclampsia
* Increased perinatal mortality
■ PP complications:
* Pulmonary edema
* Renal failure
* Heart failure
* Encephalopathy
* Stroke
Hypertensive Drugs
⚬ __________ (beta blocker)– drug of choice in pregnancy, can be given PO or IV
⚬ __________ (vasodilator) – given for severe range blood pressures not controlled by labetalol or nifedipine
⚬ Nifedipine (calcium channel blocker) – given PO especially if no IV access
⚬ NOTE: Ace inhibitors are contraindicated in pregnancy (“prils”)! They can cause fetal renal damage in the 2nd & 3rd trimester.
⚬ Labetalol (beta blocker)– drug of choice in pregnancy, can be given PO or IV
⚬ Hydralazine (vasodilator) – given for severe range blood pressures not controlled by labetalol or nifedipine
⚬ Nifedipine (calcium channel blocker) – given PO especially if no IV access
⚬ NOTE: Ace inhibitors are contraindicated in pregnancy (“prils”)! They can cause fetal renal damage in the 2nd & 3rd trimester.
Hypertension in Pregnancy cont’d
⚬ Preeclampsia
■ Pregnancy-specific syndrome in which hypertension and __________ develop after 20 weeks of gestation in a previously normotensive woman
■ Proteinuria is indicator of preeclampsia
⚬ Chronic hypertension superimposed on preeclampsia
■ Woman with chronic hypertension may acquire preeclampsia or eclampsia
■ Increases morbidity for both mother and fetus
⚬ Eclampsia
■ Onset of _________ activity or coma in a woman with preeclampsia who has no history of preexisting _________ activity
⚬ Preeclampsia
■ Pregnancy-specific syndrome in which hypertension and proteinuria develop after 20 weeks of gestation in a previously normotensive woman
■ Proteinuria is indicator of preeclampsia
⚬ Chronic hypertension superimposed on preeclampsia
■ Woman with chronic hypertension may acquire preeclampsia or eclampsia
■ Increases morbidity for both mother and fetus
⚬ Eclampsia
■ Onset of seizure activity or coma in a woman with preeclampsia who has no history of preexisting seizure activity
Preeclampsia * Etiology
⚬ Signs and symptoms typically develop during pregnancy but may appear in PP.
⚬ Associated high-risk factors
■ Family history, multifetal pregnancy, primigravidity, African-American race, obesity, maternal age > 35 years, pre-existing medical or genetic conditions
- Pathophysiology
⚬ Progressive disorder with __________ as the root cause
⚬ Caused by disruptions in placental __________ and endothelial cell dysfunction
■ Poor perfusion from vasospasm and reduced plasma volume
⚬ Arteriolar vasospasm diminishes diameter of blood vessels, which impedes blood flow to all organs and increase BP
⚬ Function in organs (placenta, kidneys, liver, brain) depressed as much as 40%-60%
⚬ Signs and symptoms typically develop during pregnancy but may appear in PP.
⚬ Associated high-risk factors
■ Family history, multifetal pregnancy, primigravidity, African-American race, obesity, maternal age > 35 years, pre-existing medical or genetic conditions
- Pathophysiology
⚬ Progressive disorder with placenta as the root cause
⚬ Caused by disruptions in placental perfusion and endothelial cell dysfunction
■ Poor perfusion from vasospasm and reduced plasma volume
⚬ Arteriolar vasospasm diminishes diameter of blood vessels, which impedes blood flow to all organs and increase BP
⚬ Function in organs (placenta, kidneys, liver, brain) depressed as much as 40%-60%
Diagnosis of Preeclampsia
Blood Pressure
➢ Systolic blood pressure of ≥ ____mm Hg OR diastolic blood pressure of ≥ ___mm Hg on two occasions at least 4 hours apart OR
➢ Systolic blood pressure of 160 mm 110 mm Hg or more
AND
Proteinuria
➢ ____ mg or more per 24-hour urine collection OR
➢ Protein/creatinine ratio of 0.3 or more OR
➢ Dipstick reading of __+ (used only if other quantitative methods not available)
Blood Pressure
➢ Systolic blood pressure of ≥ 140 mm Hg OR diastolic blood pressure of ≥ 90 mm Hg on two occasions at least 4 hours apart OR
➢ Systolic blood pressure of 160 mm 110 mm Hg or more
AND
Proteinuria
➢ 300 mg or more per 24-hour urine collection OR
➢ Protein/creatinine ratio of 0.3 or more OR
➢ Dipstick reading of 2+ (used only if other quantitative methods not available)
Preeclampsia with Severe Features
➢Systolic blood pressure of ____ mm
____ mm Hg or more.
➢Thrombocytopenia
➢Renal insufficiency
➢Pulmonary edema
➢Impaired liver function
➢New onset of __________
➢Systolic blood pressure of 160 mm
110 mm Hg or more.
➢Thrombocytopenia
➢Renal insufficiency
➢Pulmonary edema
➢Impaired liver function
➢New onset of headache
Preeclampsia cont’d * Care management
⚬ Identifying & preventing preeclampsia
■ Prevention for pregnant women at low risk for preeclampsia
* Management of gestational weight gain within recommendations
* A prepregnancy _____________ diet, high in vegetables, fish, legumes and nuts
■ Women at high risk for preeclampsia
* Low-dose _______, started before 16 weeks of gestation.
* Increased rest at home in the third trimester
* Blood pressure management
⚬ Identifying & preventing preeclampsia
■ Prevention for pregnant women at low risk for preeclampsia
* Management of gestational weight gain within recommendations
* A prepregnancy Mediterranean diet, high in vegetables, fish, legumes and nuts
■ Women at high risk for preeclampsia
* Low-dose aspirin, started before 16 weeks of gestation.
* Increased rest at home in the third trimester
* Blood pressure management
Preeclampsia cont’d
- Interventions
⚬ Gestational hypertension and preeclampsia w/o severe features
■ Initial laboratory evaluation - Serum creatinine, platelet count, and ____ enzymes.
■ Weekly evaluation
* Hematocrit, platelet count, serum creatinine, and liver function tests
■ Evaluated for signs or symptoms of severe features
* Severe ________, blurred/ double vision, mental confusion, right U.Q. abdominal or epigastric pain, nausea or vomiting, SOB, and decreased ________ output
* BP monitored frequently and proteinuria assessed weekly
■ Fetal evaluation
* Daily fetal ____________counts
* Nonstress testing or a biophysical profile once or twice weekly
* Ultrasound evaluation of amniotic fluid status & determination of estimated fetal weight performed when preeclampsia diagnosed and serially, depending on findings.
* Doppler blood flow studies are recommended if IUGR is suspected
* Typically early delivery is indicated at 37 weeks or earlier if severe features.
- Interventions
⚬ Gestational hypertension and preeclampsia w/o severe features
■ Initial laboratory evaluation - Serum creatinine, platelet count, and liver enzymes.
■ Weekly evaluation
* Hematocrit, platelet count, serum creatinine, and liver function tests
■ Evaluated for signs or symptoms of severe features
* Severe headaches, blurred/ double vision, mental confusion, right U.Q. abdominal or epigastric pain, nausea or vomiting, SOB, and decreased urinary output
* BP monitored frequently and proteinuria assessed weekly
■ Fetal evaluation
* Daily fetal movement counts
* Nonstress testing or a biophysical profile once or twice weekly
* Ultrasound evaluation of amniotic fluid status & determination of estimated fetal weight performed when preeclampsia diagnosed and serially, depending on findings.
* Doppler blood flow studies are recommended if IUGR is suspected
* Typically early delivery is indicated at 37 weeks or earlier if severe features.
Preeclampsia - * Interventions cont’d
⚬ Severe gestational hypertension and preeclampsia with severe features
■ Hospitalized immediately
■________________ to prevent eclamptic seizures
■ Antihypertensive medication to lower severe levels of hypertension.
■ Maternal assessments
* BP, urine output, cerebral status, presence of epigastric pain and/or tenderness, labor, or vaginal bleeding
■ Lab evaluation includes ________ count, liver enzymes, and serum __________
■ Fetal assessment - continuous electronic FHR monitoring, biophysical profile, ultrasound evaluation of fetal growth and amniotic fluid volume
* If evidence of fetal growth restriction found, umbilical artery Doppler velocimetry recommended
▪ Early delivery. If necessary before 37 weeks, give glucocorticoids (____________) for baby lungs
⚬ Severe gestational hypertension and preeclampsia with severe features
■ Hospitalized immediately
■ Magnesium sulfate to prevent eclamptic seizures
■ Antihypertensive medication to lower severe levels of hypertension.
■ Maternal assessments
* BP, urine output, cerebral status, presence of epigastric pain and/or tenderness, labor, or vaginal bleeding
■ Lab evaluation includes platelet count, liver enzymes, and serum creatinine
■ Fetal assessment - continuous electronic FHR monitoring, biophysical profile, ultrasound evaluation of fetal growth and amniotic fluid volume
* If evidence of fetal growth restriction found, umbilical artery Doppler velocimetry recommended
▪ Early delivery. If necessary before 37 weeks, give glucocorticoids (bethamethosone)
Preeclampsia - * Care management cont’d
⚬ Assessment
■ Physical examination
* Blood pressure
* Edema - dependent, pitting
* Deep tendon reflexes
* Clonus
■ Laboratory tests
* Platelets
* Creatinine
* _____ function
* Urine _______
⚬ Assessment
■ Physical examination
* Blood pressure
* Edema - dependent, pitting
* Deep tendon reflexes
* Clonus
■ Laboratory tests
* Platelets
* Creatinine
* Liver function
* Urine protein
Preeclampsia * Interventions
⚬ Intent of emergency interventions
■ Prevent self injury
■ Ensure adequate oxygenation
■ Reduce aspiration risk
■ Establish seizure control with
Magnesium sulfate
* Monitor for reflexes, __________, urinary output, LOC
* ________________ - antidote, should be available at bedside
⚬ Intent of emergency interventions
■ Prevent self injury
■ Ensure adequate oxygenation
■ Reduce aspiration risk
■ Establish seizure control with
Magnesium sulfate
* Monitor for reflexes, respirations, urinary output, LOC
* Calcium gluconate - antidote, should be available at bedside
Preeclampsia - HELLP syndrome
⚬ Lab diagnostic variant of severe preeclampsia involves hepatic dysfunction, characterized by:
■ ________
■ Elevated _____ enzymes
■ Low _________
⚬ Associated with increased risk for:
■ __________ edema, renal failure, liver hemorrhage or failure, disseminated intravascular coagulation (DIC), placental abruption, acute respiratory distress syndrome (ARDS), sepsis, stroke, fetal and maternal death
⚬ Lab diagnostic variant of severe preeclampsia involves hepatic dysfunction, characterized by:
■ Hemolysis
■ Elevated liver enzymes
■ Low platelets
⚬ Associated with increased risk for:
■ Pulmonary edema, renal failure, liver hemorrhage or failure, disseminated intravascular coagulation (DIC), placental abruption, acute respiratory distress syndrome (ARDS), sepsis, stroke, fetal and maternal death
Eclampsia
Signs of preeclampsia (hypertension & proteinuria) with onset of seizures
Preceding s/s
⚬ Headache, ________ vision, photophobia, epigastric/____ abdominal pain, altered mental status
- Plan of care
o Immediate - protect from injury and protect airway
o Magnesium sulfate is drug of choice and hypertensive medications if needed
o Postpartum nursing care
Signs of preeclampsia (hypertension & proteinuria) with onset of seizures
Preceding s/s
⚬ Headache, blurred vision, photophobia, epigastric/RUQ abdominal pain, altered mental status
- Plan of care
o Immediate - protect from injury and protect airway
o Magnesium sulfate is drug of choice and hypertensive medications if needed
o Postpartum nursing care
You’re providing education to a nursing student about the pathophysiology of preeclampsia. Which
statement demonstrates that the student understood
how this condition develops?
A. “The basal arteries of the myometrium fail to widen to support blood flow to the placenta.”
B. “The placenta experiences ischemia because the
spiral arteries of the uterus fail to reshape and increase in diameter.”
C. “The cardiovascular system of the mother fails to
compensate for the increased blood flow from the
fetus and placental ischemia occurs.”
D. “If the mother experience uncontrolled hypertension and proteinuria, it compromises blood flow to the placenta and leads to preeclampsia.”
B. “The placenta experiences ischemia because the
spiral arteries of the uterus fail to reshape and
increase in diameter.”
When preeclampsia occurs, it is because the spiral
arteries of the uterus failed to widen in diameter due
to poor trophoblast invasion during the beginning of
the pregnancy. Overtime, this causes problems
(usually after 20 weeks gestation) and the placenta
experiences ischemia. When the placenta becomes
ischemic is releases substances into mom’s
circulation that are very toxic to her endothelial cells,
which causes all the signs and symptoms seen in
preeclampsia. Severity varies in patients.
Which findings below could indicate the development of preeclampsia in a patient that would need to be reported to the physician? Select all that apply:
❑ A. Blood pressure 165/91
❑ B. 3+ dipstick urine protein
❑ C. Platelet count 187,000/unit
❑ D. AST 14, ALT 18
❑ E. Contractions
❑ F. Headache
The answers are A, B and F.
Signs and symptoms of preeclampsia include: proteinuria (>1+ dipstick urine protein or >300 mg/dL 24 hour urine protein, hypertension >140/90…two reading at least 4-6 hours apart or severe range BP
>160/110), swelling in face, eyes, extremities, headaches, vision changes, etc.
Which finding below indicates Magnesium Sulfate toxicity and requires you to notify the physician?
A. Deep tendon reflexes +4
B. Urinary output of 600 mL over 12 hours
C. Clonus presenting in the lower extremities
D. Respiratory rate of 8 breaths per minute
E. O2 saturation 98%
D. Respiratory rate of 8 breaths per minute
The nurse should monitor for Magnesium Sulfate toxicity. Signs of this include:
decreased or absent reflexes (finding of 4+ Deep tendon reflex is considered HYPERreflexia), Respiratory rate less than 12 breaths per minute, Urinary output of less than 30 mL/hr, EKG changes.
Bonus Question: What medication would the nurse anticipate administering as the antidote for magnesium sulfate toxicity?
Calcium gluconate
Hyperemesis Gravidarum
- Excessive __________
- Loss of __%of prepregnancy weight
- Accompanied by:
⚬ Dehydration
⚬ Electrolyte imbalance
⚬ Nutritional deficiencies
⚬ Ketosis
⚬ Acetonuria - Plan of care: correct electrolyte imbalance, hydrate, control N&V
- Excessive vomiting
- Loss of 5% of prepregnancy weight
- Accompanied by:
⚬ Dehydration
⚬ Electrolyte imbalance
⚬ Nutritional deficiencies
⚬ Ketosis
⚬ Acetonuria - Plan of care: correct electrolyte imbalance, hydrate, control N&V
Hemorrhagic Disorders
Bleeding in pregnancy jeopardizes both maternal and fetal well-being
⚬ Maternal blood loss decreases ________-carrying capacity, increases risk for:
■ Hypovolemia
■ Anemia
■ Infection
■ Preterm labor
■ Adverse oxygen delivery
⚬ Fetal risks from maternal hemorrhage:
■ ________/blood loss
■ Hypoxemia, _______, anoxia
■ Preterm birth
Bleeding in pregnancy jeopardizes both maternal and fetal well-being
⚬ Maternal blood loss decreases oxygen-carrying capacity, increases risk for:
■ Hypovolemia
■ Anemia
■ Infection
■ Preterm labor
■ Adverse oxygen delivery
⚬ Fetal risks from maternal hemorrhage:
■ Anemia/blood loss
■ Hypoxemia, hypoxia, anoxia
■ Preterm birth